Verition Fund Management
RXST icon

Verition Fund Management’s RxSight RXST Stock Holding History

Verition Fund Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,613
Closed -$423K – 3354
2025
Q4 		$423K Buy
40,613
+1,701
+4% +$17.1K ﹤0.01% 2791
2025
Q3 		$350K Sell
38,912
-87,441
-69% -$767K ﹤0.01% 3225
2025
Q2 		$1.64M Buy
126,353
+68,328
+118% +$1.03M 0.01% 2098
2025
Q1 		$1.47M Buy
58,025
+13,445
+30% +$400K 0.01% 1810
2024
Q4 		$1.53M Buy
44,580
+24,907
+127% +$1.12M 0.01% 1738
2024
Q3 		$972K Sell
19,673
-1,678
-8% -$86K ﹤0.01% 1905
2024
Q2 		$1.28M Sell
21,351
-7,655
-26% -$437K 0.01% 1522
2024
Q1 		$1.5M Buy
29,006
+23,009
+384% +$1.13M 0.01% 1387
2023
Q4 		$242K Buy
+5,997
New +$176K ﹤0.01% 1913
2023
Q3 		– Sell
-9,431
Closed -$272K – 2641
2023
Q2 		$272K Buy
+9,431
New +$210K ﹤0.01% 1629

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Verition Fund Management's RXST Position: Q1 2026 in Review

Verition Fund Management sold out of RxSight (RXST) in Q1 2026, closing a stake of 40,613 shares — an estimated $423K sold.

Verition Fund Management first reported a position in RXST in Q2 2023 and held it in 10 quarters. The position peaked at $1.64M in Q2 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Verition Fund Management reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 40,613 RxSight shares in Q1 2026, an estimated $423K.
  • Verition Fund Management first reported a position in RxSight in Q2 2023 and held it in 10 quarters.
  • Verition Fund Management's RxSight position peaked at $1.64M in Q2 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.